Valo Health, Inc , a tech­nol­o­gy com­pa­ny focused on uti­liz­ing large scale data and arti­fi­cial intel­li­gence (“AI”) dri­ven com­pu­ta­tion to dis­cov­er and devel­op ther­a­peu­tics announced the appoint­ment of Lisa P. Young to its Board of Direc­tors and as the chair of its Audit Com­mit­tee. Young is a sea­soned board mem­ber and glob­al busi­ness leader with over 36 years of cross-sec­tor, inter­na­tion­al expe­ri­ence in pub­lic account­ing and pro­fes­sion­al services.

 

“I am hon­ored to wel­come Lisa to the Valo Board of Direc­tors. Her near­ly four decades at EY in work­ing with new busi­ness mod­els and tech­nol­o­gy lead­ers across mul­ti­ple indus­tries have armed her with the exper­tise to exceed in lead­ing our Board’s audit com­mit­tee,” said Valo CEO and Founder, David Berry, PhD, MD. ​“Lisa brings a dis­tinc­tive skillset and shares in our phi­los­o­phy that suc­cess starts with cul­ture. I am excit­ed to part­ner with Lisa as we build the next phase of Valo.”

 

“I am thrilled to join Valo Health’s board of direc­tors and to chair its audit com­mit­tee,” said Young. ​“I am inspired by Valo’s mis­sion to devel­op bet­ter ther­a­peu­tics for patients faster using large scale human-cen­tric data, and by the team that has come togeth­er to bring this excit­ing vision to real­i­ty. I look for­ward to apply­ing what I’ve learned through­out my career to com­ple­ment the orga­ni­za­tion to future successes.”

 

Young was with Ernst & Young LLP  for 36 years, with 24 of those years as a part­ner, and held sev­er­al busi­ness lead­er­ship and client serv­ing roles includ­ing Senior Glob­al Client Ser­vice Part­ner, Amer­i­c­as Pro­fes­sion­al Prac­tice Part­ner and Glob­al Cap­i­tal Mar­kets Part­ner in EY’s nation­al office. Young serves on the Board of Direc­tors of Accelus, Inc., a com­pa­ny focused on min­i­mal­ly inva­sive spine surgery tech­nol­o­gy, and chairs their audit and finance com­mit­tee and is a mem­ber of the nom­i­nat­ing and cor­po­rate gov­er­nance com­mit­tee, and on the Board of Direc­tors of Tex­tain­er Group Hold­ings as a direc­tor and mem­ber of their audit and risk com­mit­tee and the com­pen­sa­tion com­mit­tee. She serves as the Advance­ment Chair of the Board of Trustees for the Colum­bus Muse­um of Art, a mem­ber and Finance Chair of the Board of Direc­tors of the Dal­las Black Dance The­atre and for FringeArts in Philadel­phia, and a mem­ber of the Texas Tech Uni­ver­si­ty Rawls Col­lege of Busi­ness Advi­so­ry Coun­cil. Young holds a Bach­e­lor of Busi­ness Admin­is­tra­tion, Cum Laude, in Finance and Account­ing from Texas Tech Uni­ver­si­ty, and is a cer­ti­fied pub­lic accountant.

 

Source: Valo Health

«« InnoScot Health: Decision Support Programme Advances to National Service


Europe Takes Lead in AI Regulation »»



Latest Articles

Valo Health, Inc ,arti­fi­cial intel­li­gence,AI,Lisa P. Young,Board of Direc­tors, Audit Com­mit­tee Valo Health, Inc , a tech­nol­o­gy com­pa­ny focused on uti­liz­ing large scale data and arti­fi­cial intel­li­gence (“AI”) dri­ven com­pu­ta­tion to dis­cov­er and devel­op ther­a­peu­tics announced the appoint­ment of Lisa P. Young to its Board of Direc